CO27 | Pseudomonas aeruginosa MDR strain bacteraemia successfully treated with piperacillin/tazobactam: when beta-lactam continuous infusion, therapeutic drug monitoring and fosfomycin combination make everything easier
A. Pagotto1, A. Acquasanta1, L. Martini1, A. Sartor2, C. Tascini1 | 1Infectious Diseases Division, Department of Medicine (DAME), University of Udine and Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, 2Microbiology Unit, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Premises: Pseudomonas aeruginosa is a common cause of healthcare-associated infections. In case of sepsis, beta-lactam antibiotics continuous infusion (CI) and therapeutic drug monitoring (TDM) guided therapy, allow to reach a higher rate of clinical and microbiological cure. Fosfomycin is known to retain good antibiofilm activity and a potential synergistic effect when added to beta-lactams, even against P. aeruginosa MDR strains.
Case description: A 62 years old man, affected by squamous cell carcinoma extended to the pelvic region, after an attempt of epicistostomy placement, developed fever with high C-reactive protein (CRP 268.74 mg/L) and procalcitonin (PCT 39.32 ng/mL) values. Urine and blood cultures were taken and empiric iv piperacillin/tazobactam 18gr CI was started; cause of fever persistence, beta-lactam dosage was brought to 20.5gr and iv fosfomycin 12gr CI was added. Cultures revealed P. aeruginosa growth with MDR profile: cefepime I8 mg/L, ceftazidime I8 mg/L, ceftolozan-tazobactam S1 mg/L, ciprofloxacin I0.5 mg/L, fosfomycin R>64 mg/L, meropenem R16 mg/L, piperacillina-tazobactam R32 mg/L. No organ involvement was documented. Due to persistent apyrexia, CRP, PCT and blood culture negativization, we maintained the same antibiotic treatment, despite of resistance profile. Piperacillin/tazobactam TDM showed a concentration of 72.55 mg/L, more than twice the MIC value for P. aeruginosa.
Conclusions: Piperacillin/tazobactam CI, in association with fosfomycin and TDM, could be a good choice, even in case of P. aeruginosa MDR infection without organ involvement.
Altmetrics
Downloads
Citations
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.